Yihui Zheng
Overview
Explore the profile of Yihui Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu M, Lin J, Zhuge Z, Zheng Y, Ye S, Wang X, et al.
Infect Drug Resist
. 2024 Dec;
17:5277-5286.
PMID: 39619726
Purpose: Neonatal bacterial meningitis (NBM) is a serious disease with high morbidity and mortality. This study aimed to establish a foundation for the selection of empirical antibiotics for NBM through...
2.
Hu X, Zheng Y, Fang M, Liang Z, Wen C, Lin J, et al.
Respir Res
. 2024 Nov;
25(1):412.
PMID: 39568008
Background: Abnormal pulmonary vascular development poses significant clinical challenges for infants with bronchopulmonary dysplasia (BPD). Although numerous factors have been suggested to control the development of pulmonary blood vessels, the...
3.
Fang Y, Zheng Y, Gao Q, Pang M, Wu Y, Feng X, et al.
Redox Rep
. 2024 Sep;
29(1):2394714.
PMID: 39284589
Neonatal hypoxic-ischemic encephalopathy (HIE) is a severe disease with a poor prognosis, whose clinical treatment is still limited to therapeutic hypothermia with limited efficacy. Perillyl alcohol (POH), a natural monoterpene...
4.
Luo M, Chen H, Xiao G, Zheng Y, Yang C, Lin H
Gastroenterol Rep (Oxf)
. 2024 Jun;
12:goae068.
PMID: 38912039
No abstract available.
5.
Feng X, Zheng Y, Mao N, Shen M, Chu L, Fang Y, et al.
Int Immunopharmacol
. 2024 May;
134:112257.
PMID: 38759366
Background: Hypoxic-ischemic encephalopathy (HIE) is a major contributor to neonatal mortality and neurodevelopmental disorders, but currently there is no effective therapy drug for HIE. Mitochondrial dysfunction plays a pivotal role...
6.
Xiao G, Zheng Y, Chen H, Luo M, Yang C, Ren D, et al.
J Transl Med
. 2024 Feb;
22(1):134.
PMID: 38311726
Background: Overweight and obesity are established risk factors for various types of cancers including colorectal cancer (CRC). However the underlying molecular mechanisms remain unclear. An in-depth understanding of the oncologic...
7.
Chen H, Wan X, He Q, Xiao G, Zheng Y, Luo M, et al.
Biomol Biomed
. 2024 Jan;
24(4):871-887.
PMID: 38289380
The cellular characteristics of intestinal cells involved in the therapeutic effects of astragaloside IV (AS-IV) for treating slow transit constipation (STC) remain unclear. This study aimed to determine the dynamics...
8.
Wan X, Zhou Q, Chen H, Li Z, Mo M, Liu Z, et al.
Front Pharmacol
. 2023 Dec;
14:1196210.
PMID: 38074145
Slow transit constipation (STC) is a common gastrointestinal disorder characterized by altered gut microbiota and reduced number of enterochromaffin cells (ECs). Astragaloside IV (AS-IV), a low drug permeability saponin, has...
9.
Qin P, Chen H, Wang Y, Huang L, Huang K, Xiao G, et al.
Cell Rep Med
. 2023 Oct;
4(10):101231.
PMID: 37852187
Neoadjuvant chemotherapy (NAC) for rectal cancer (RC) shows promising clinical response. The modulation of the tumor microenvironment (TME) by NAC and its association with therapeutic response remain unclear. Here, we...
10.
Zheng Y, Zhu T, Chen B, Fang Y, Wu Y, Feng X, et al.
Int Immunopharmacol
. 2023 Oct;
124(Pt B):111030.
PMID: 37844463
Hypoxic-ischemic encephalopathy (HIE) is a perinatal brain disease caused by hypoxia in neonates. It is one of the leading causes of neonatal death in the perinatal period, as well as...